Brian McKelligon

2021

In 2021, Brian McKelligon earned a total compensation of $2.3M as Chief Executive Officer at Akoya Biosciences, a 339% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$173,599
Option Awards$1,700,389
Salary$393,333
Total$2,267,321

McKelligon received $1.7M in option awards, accounting for 75% of the total pay in 2021.

McKelligon also received $173.6K in non-equity incentive plan and $393.3K in salary.

Rankings

In 2021, Brian McKelligon's compensation ranked 5,546th out of 12,406 executives tracked by ExecPay. In other words, McKelligon earned more than 55.3% of executives.

ClassificationRankingPercentile
All
5,546
out of 12,406
55th
Division
Manufacturing
2,344
out of 5,492
57th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
288
out of 798
64th
Industry group
Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments
88
out of 206
57th
Industry
Laboratory Analytical Instruments
41
out of 90
54th
Source: SEC filing on April 19, 2022.

McKelligon's colleagues

We found two more compensation records of executives who worked with Brian McKelligon at Akoya Biosciences in 2021.

2021

Frederic Pla

Akoya Biosciences

Chief Operating Officer

2021

Joseph Driscoll

Akoya Biosciences

Chief Financial Officer

News

In-depth

You may also like